Assisted reproductive technology market seen reaching $56.96 billion by 2030

The assisted reproductive technology market is projected to grow from $37.06 billion in 2025 to $56.96 billion by 2030, according to The Business Research Company. Rising infertility rates, wider access to fertility treatments and medical advances are driving demand across Europe, North America and other regions.

Why it matters: - The assisted reproductive technology market is expanding as more people seek fertility treatment and clinics scale up capacity. - The market’s projected growth signals rising healthcare spending on reproductive services and related diagnostics. - Wider use of ART affects patients, families and healthcare systems by increasing access to treatment options for infertility.

What happened: - The Business Research Company released The Assisted Reproductive Technology Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035. - The report estimates the market will grow from $37.06 billion in 2025 to $40.46 billion in 2026. - The report forecasts the market will reach $56.96 billion by 2030. - The report puts the market on track for a 9.2% CAGR in 2026 and an 8.9% CAGR through 2030. - Europe held the largest share of the assisted reproductive technology market in 2025. - North America ranked second among regional markets.

The details: - Assisted reproductive technology covers egg retrieval, laboratory fertilization and embryo transfer back into the uterus. - ART can use donor eggs, donor sperm or previously frozen embryos. - Rising infertility rates are a central driver of demand. - The World Health Organization reported in April 2023 that 1 in 6 adults, or about 17.5% of the global adult population, experience infertility. - Advances in precision fertility diagnostics and minimally invasive procedures are improving success rates and patient experience. - Investment in fertility treatment infrastructure and broader use of genetic testing are also supporting growth. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The Business Research Company also said its 2026 reports include market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, and updated graphics and tables. - A free sample of the report is available here. - The full report is available here.

Between the lines: - The forecast points to steady demand rather than a short-term spike, with growth expected to continue even as the market scales. - The combination of infertility prevalence, wider social acceptance and better medical tools suggests ART is moving further into mainstream care. - Regional leadership in Europe and North America suggests mature markets remain key revenue centers while other regions continue to develop.

What's next: - Fertility providers are likely to keep investing in diagnostics, procedures and lab capacity to meet rising demand. - Genetic testing and minimally invasive treatment methods are likely to play a larger role in future ART offerings. - Market growth will likely track broader access to fertility care and continued expansion of clinic networks.

The bottom line: - ART is moving from a specialized treatment category into a larger, faster-growing global fertility market with broad demand drivers and long runway for expansion.